TY - JOUR
T1 - Analysis of purified wild type and mutant adenovirus particles by silac based quantitative proteomics
AU - Alqahtani, Ali
AU - Heesom, Kate
AU - Bramson, Jonathan L.
AU - Curiel, David
AU - Ugai, Hideyo
AU - Matthews, David A.
N1 - Publisher Copyright:
© 2014 The Authors.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - We used SILAC (stable isotope labelling of amino acids in cell culture) and high-throughput quantitative MS mass spectrometry to analyse the protein composition of highly purified WT wild type adenoviruses, mutant adenoviruses lacking an internal protein component (protein V) and recombinant adenoviruses of the type commonly used in gene therapy, including one virus that had been used in a clinical trial. We found that the viral protein abundance and composition were consistent across all types of virus examined except for the virus lacking protein V, which also had reduced amounts of another viral core protein, protein VII. In all the samples analysed we found no evidence of consistent packaging or contamination with cellular proteins. We believe this technique is a powerful method to analyse the protein composition of this important gene therapy vector and genetically engineered or synthetic virus-like particles. The raw data have been deposited at proteomexchange, identifer PXD001120.
AB - We used SILAC (stable isotope labelling of amino acids in cell culture) and high-throughput quantitative MS mass spectrometry to analyse the protein composition of highly purified WT wild type adenoviruses, mutant adenoviruses lacking an internal protein component (protein V) and recombinant adenoviruses of the type commonly used in gene therapy, including one virus that had been used in a clinical trial. We found that the viral protein abundance and composition were consistent across all types of virus examined except for the virus lacking protein V, which also had reduced amounts of another viral core protein, protein VII. In all the samples analysed we found no evidence of consistent packaging or contamination with cellular proteins. We believe this technique is a powerful method to analyse the protein composition of this important gene therapy vector and genetically engineered or synthetic virus-like particles. The raw data have been deposited at proteomexchange, identifer PXD001120.
UR - http://www.scopus.com/inward/record.url?scp=84908285649&partnerID=8YFLogxK
U2 - 10.1099/vir.0.068221-0
DO - 10.1099/vir.0.068221-0
M3 - Article
C2 - 25096814
AN - SCOPUS:84908285649
SN - 0022-1317
VL - 95
SP - 2504
EP - 2511
JO - Journal of General Virology
JF - Journal of General Virology
ER -